Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exact Sciences Corporation - Common Stock
(NQ:
EXAS
)
53.14
-0.51 (-0.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out
June 25, 2025
BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and Exact Sciences.
Via
Benzinga
Topics
Artificial Intelligence
1 of Wall Street’s Favorite Stock with Promising Prospects and 2 to Turn Down
June 17, 2025
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...
Via
StockStory
Topics
Economy
A Look Back at Immuno-Oncology Stocks’ Q1 Earnings: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Pack
June 11, 2025
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the immuno-oncology industry, including Exact Sciences (NASDAQ:EXAS) and its peers.
Via
StockStory
Topics
Artificial Intelligence
3 Mid-Cap Stocks in the Doghouse
June 02, 2025
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...
Via
StockStory
Earnings Scheduled For May 1, 2025
May 01, 2025
Via
Benzinga
Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap
May 28, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences to Participate in June Investor Conference
May 27, 2025
From
Exact Sciences Corp.
Via
Business Wire
3 Low-Volatility Stocks Walking a Fine Line
May 23, 2025
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Via
StockStory
Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025
May 22, 2025
From
Exact Sciences Corp.
Via
Business Wire
EXAS Q1 Earnings Call: Outperformance Driven by Commercial Execution, New Products, and Margin Expansion
May 16, 2025
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) announced better-than-expected revenue in Q1 CY2025, with sales up 10.9% year on year to $706.8 million. The company’s full-year revenue...
Via
StockStory
1 Healthcare Stock Worth Investigating and 2 to Ignore
May 16, 2025
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...
Via
StockStory
Topics
Stocks
2 Brilliant Stocks to Buy With $200 and Hold for 5 Years
May 14, 2025
Via
The Motley Fool
Exact Sciences Earns 2025 Great Place To Work® Certification™
May 12, 2025
From
Exact Sciences Corp.
Via
Business Wire
Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
May 04, 2025
Top performing large-cap stocks in the last week: DUOL, CRWV, THC, CARR, SMMT, AUR, ANET, TT, DXCM, XPO. Most had positive financial results and raised guidance.
Via
Benzinga
Exact Sciences (EXAS) Stock Trades Up, Here Is Why
May 02, 2025
Shares of diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) jumped 15.2% in the morning session after the company reported strong first quarter 2025 results which beat analysts' revenue and...
Via
StockStory
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday
May 02, 2025
Via
Benzinga
Cancer Diagnostic Firm Exact Sciences' CEO Says Strong Q1 Paves Way For 'Transformative' 2025, Lifts Annual Guidance
May 02, 2025
Exact Sciences posted better-than-expected Q1 results and lifted its 2025 outlook, signaling confidence in growth and operational momentum.
Via
Benzinga
Exact Sciences to Participate in May Investor Conference
May 02, 2025
From
Exact Sciences Corp.
Via
Business Wire
Why Twilio Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
May 02, 2025
Via
Benzinga
Exact Sciences (NASDAQ:EXAS) Posts Better-Than-Expected Sales In Q1, Stock Soars
May 01, 2025
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.9% year on year to $706.8 million. The company’s full-year revenue...
Via
StockStory
12 Health Care Stocks Moving In Thursday's After-Market Session
May 01, 2025
Via
Benzinga
Exact Sciences Hikes Its Full-Year Outlook. But There's One First-Quarter Drawback.
May 01, 2025
The company hiked its sales guidance for the year, but reported steeper-than-expected first-quarter losses.
Via
Investor's Business Daily
Topics
Government
Exact Sciences Announces First-Quarter 2025 Results
May 01, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences (EXAS) Reports Q1: Everything You Need To Know Ahead Of Earnings
April 30, 2025
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) will be reporting results tomorrow after the bell. Here’s what to look for.
Via
StockStory
Topics
Artificial Intelligence
Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025
April 29, 2025
From
Exact Sciences Corp.
Via
Business Wire
2 Reasons to Like EXAS (and 1 Not So Much)
April 24, 2025
What a brutal six months it’s been for Exact Sciences. The stock has dropped 37.2% and now trades at $44.10, rattling many shareholders. This may have investors wondering how to approach the...
Via
StockStory
Exact Sciences Launches New Test To Monitor Cancer Recurrence: Retail’s Optimistic
April 22, 2025
Patients who test positive for circulating tumor DNA with the Oncodetect test during surveillance are 50 times more likely to experience cancer recurrence than those with negative results, the company...
Via
Stocktwits
Topics
Government
Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test
April 22, 2025
From
Exact Sciences Corp.
Via
Business Wire
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
April 17, 2025
A revolution in oncology could help cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.
Via
Investor's Business Daily
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
April 15, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Exact Sciences (NASDAQ:EXAS) and its peers.
Via
StockStory
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.